Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'c-Abl'

Search results for: 'c-Abl'

Items 1-10 of 43

Page
per page
  1. Triacsin C
    B7070 Triacsin C
    Target: Synthases/Synthetases
    Summary: A potent inhibitor of acyl-CoA synthetase
      Soluble in DMSO
  2. Nilotinib(AMN-107)
    A8232 Nilotinib(AMN-107)
     1 Citation
    Target: Bcr-Abl
    Summary: Bcr-Abl kinase inhibitor,selective
      ≥26.5 mg/mL
  3. GNF 5
    A8604 GNF 5
    Target: Bcr-Abl
    Summary: Bcr-Abl inhibitor
  4. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  5. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 inhibitor,potent and selective
      ≥25.15 mg/mL
  6. Ki20227
    A3527 Ki20227
    Target: c-Fms tyrosine kinase
    Summary: C-Fms tyrosine kinase inhibitor
      ≥48.1 mg/mL
  7. GW5074
    B1405 GW5074
    Summary: C-Raf inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥21.9 mg/mL
  8. GSK1070916
    A4127 GSK1070916
    Target: Aurora Kinases
    Summary: Aurora B/C inhibitor
      ≥25.4 mg/mL
  9. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  10. VX-680 (MK-0457,Tozasertib)
    A4111 VX-680 (MK-0457,Tozasertib)
    Target: Aurora Kinases
    Summary: Aurora kinase inhibitor
      ≥23.25 mg/mL

Items 1-10 of 43

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 3item
  2. Apoptosis 3item
  3. Chromatin/Epigenetics 4item
  4. MAPK Signaling 5item
  5. Tyrosine Kinase 23item
  6. DNA Damage/DNA Repair 1 item
  7. PI3K/Akt/mTOR Signaling 1 item
  8. Microbiology & Virology 3item
  9. Cell Cycle/Checkpoint 4item
  10. Ubiquitination/ Proteasome 1 item
  11. TGF-β / Smad Signaling 5item
  12. Others 2item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Proteasome 1 item
  2. Raf 5item
  3. Aurora Kinases 3item
  4. mTOR 1 item
  5. Bromodomains 1 item
  6. AP-1 1 item
  7. MMP 1 item
  8. FLT3 4item
  9. Eph Receptors 2item
  10. VEGFR 9item
  11. PDGFR 7item
  12. c-Kit 3item
  13. RET 1 item
  14. Thymidylate Synthase 1 item
  15. Bcr-Abl 4item
  16. MEK 1 item
  17. FGFR 1 item
  18. MET 4item
  19. Src 4item
  20. Trk Receptors 2item
  21. EGFR 1 item
  22. JAK 1 item
  23. DNA-PK 1 item
  24. c-MET 5item
  25. PKC 2item
  26. Tie-2 1 item
  27. Farnesyl Diphosphate Synthases 1 item
  28. Ron 1 item
  29. Synthases/Synthetases 1 item
  30. P110 1 item
  31. Hck 1 item
  32. ZAP-70 1 item
  33. c-Fms tyrosine kinase 1 item
  34. HCV polymerase 2item
  35. PC-PLC 1 item
  36. Lck 1 item
Related Disease
  1. Acute Myeloid Leukemia 3item
  2. Adrenocortical Carcinoma 1 item
  3. Bladder Cancer 1 item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 6item
  6. Cancer 29item
  7. Cholangiocarcinoma 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Colon Cancer 5item
  10. Colon Carcinoma 2item
  11. Colorectal Cancer 5item
  12. Glioblastoma 3item
  13. HCV 1 item
  14. Hepatitis C 1 item
  15. Hepatocellular Carcinoma 1 item
  16. Leukemia 2item
  17. Liver Cancer 1 item
  18. Lung Cancer 4item
  19. Lung Carcinoma 2item
  20. Lymphoma 2item
  21. Melanoma 3item
  22. Multiple Myeloma 2item
  23. Non-small Cell Lung Cancer 2item
  24. Ovarian Cancer 2item
  25. Pancreatic Cancer 6item
  26. Prostate Cancer 2item
  27. Renal Cancer 1 item
  28. Renal Cell Carcinoma 2item
  29. Rheumatoid Arthritis 1 item
  30. Thyroid Cancer 4item